• Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD.

  • Nov 1 2023
  • Length: 1 hr and 24 mins
  • Podcast

Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD. cover art

Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD.

Listen for free

View show details

  • Summary

  • "I don't know how I'm going to live with myself if I don't stay true to what I believe." We evaluate the recent published work describing apabetalone, a small molecule drug from Resverlogix Corp that has been around for awhile and in clinic for other indications and is now being assessed more seriously as a potential therapeutic for FSHD. Overall, while lacking in some areas, this initial study is generally positive and supports that it is a new candidate worthy of further evaluation.

    --- Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message
    Show More Show Less
Show More Show Less

What listeners say about Assessing the case, so far, for apabetalone as a new drug candidate being investigated for FSHD.

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.